Received by email:

File: '\\office\emailin\20220708 054908 Attachment 070822  BHSC NR 30,000 Stock options.docx'

CSE:BHSC - FSE:8MV - OTC: CNVCF OFSE:8MV
NR: 070822-1


 BIOHARVEST SCIENCES INC. ANNOUNCES GRANT OF STOCK OPTIONS





VANCOUVER, BC, JULY 8, 2022 - BioHarvest Sciences Inc. ("BioHarvest" or the "Company") (CSE: BHSC) announces that it h
--->as granted 30,000 stock options to a consultant of the Company. The stock options granted will vest monthly over a 2-m
--->onth period and are exercisable to purchase a common share of the Company at a price of $0.23 per share for a term of 
--->10 years. 


About BioHarvest Sciences Inc.
BioHarvest Sciences Inc. (CSE: BHSC) is a fast-growing Biotech firm listed on the Canadian Securities Exchange. BioHar
--->vest has developed a patented bio-cell growth platform technology capable of growing the active and beneficial ingredi
--->ents in fruit and plants, at industrial scale, without the need to grow the plant itself. This technology is economica
--->l, ensures consistency, and avoids the negative environmental impacts associated with traditional agriculture. BioHarv
--->est is currently focused on nutraceuticals and the medicinal cannabis markets. Visit: www.bioharvest.com.

BioHarvest Sciences Inc.
Ilan Sobel, Chief Executive Officer

For further information, please contact:
Dave Ryan, VP Investor Relations & Director
Phone: 1 (604) 622-1186
Email: dave@bioharvest.com 

      


Forward-Looking Statements 
Information set forth in this news release includes forward-looking statements that are based on management's current 
--->estimates, beliefs, intentions, and expectations, and are subject to a number of risks and uncertainties that could ca
--->use actual results to differ materially from those described in the forward-looking statements. There is no assurance 
--->that we will achieve our objective of being a leading supplier of Cannabis. Delays and cost overruns may result in del
--->ays achieving our objectives. Projected sales of Cannabis will require the company to obtain production and / or expor
--->t licensing which cannot be assured.

All forward-looking statements are inherently uncertain and actual results may be affected by a number of material fac
--->tors beyond our control. Readers should not place undue reliance on forward-looking statements. BHSC does not intend t
--->o update forward-looking statement disclosures other than through our regular management discussion and analysis discl
--->osures. 

Neither the Canadian Securities Exchange nor its Regulation Services Provider accept responsibility for the adequacy o
--->r accuracy of this release.